ann out: new coo

it sounds like things are slowly coming together

pace isn't important as long as the wheels keep turning

Friday, 16 March 2007
OBJ APPOINTS COO
=================
Australian drug delivery company OBJ Limited (ASX: OBJ) today
announced that it has strengthened its management team with the
appointment of Dr Leearne Hinch as the company’s Chief Operations
Officer. Dr Hinch will be responsible for business development and
commercialisation of the company’s Dermaportation through-the-skin drug
delivery technology. She will work closely with Dr Ravi Kiron the company’s
US business development consultant and Dr Lucio van Rooijen who
represents the company’s European business activities.
Dr Hinch is a qualified veterinarian and experienced biotechnology
executive with strengths in strategic planning, operational management and
technology commercialisation. Dr Hinch has previously held senior
management positions with pharmaceutical, biotechnology and animal
health companies in general management, business development, sales
and marketing. Dr Hinch has a Bachelor of Veterinary Medicine and
Surgery from Murdoch University and a MBA from Curtin University.
The Board welcomes Dr Hinch’s business development and
commercialisation experience to the team as OBJ moves to commercialise
its novel TDD technologies. OBJ is now strongly positioned to advance its
drug development and business development programs as the company
seeks to license its Dermaportation technology to major cosmetic and
pharmaceutical partners in 2007.
ENDS
For more information:
Jeffrey Edwards
Managing Director
OBJ Ltd
P +618 9443 3011
M +61 417 912 211
E [email protected]
Dr Leearne Hinch
COO
OBJ Ltd
P +618 9443 3011
M +61 400 414 416
E [email protected]